Trial Profile
Morning vs evening administration of nebivolol in obese patients with mild-to-moderate hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2011
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 09 Jun 2011 New trial record
- 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.